UNITED THERAPEUTICS Corp 4

Jan Malcolm of United Therapeutics Corp had 650 RSUs vest into common stock and then sold 325 common shares at $550.59 under a 10b5-1 plan, leaving 450 shares owned directly.

On July 9, 2026, United Therapeutics Corp insider Jan Malcolm had 650 restricted stock units vest and convert into 650 shares of common stock at a stated price of $0.00, increasing his directly held common shares to 775. On July 10, 2026, he sold 325 of those common shares at $550.59 per share under a pre-arranged Rule 10b5-1 trading plan, generating proceeds of approximately $178,942 and leaving him with 450 directly owned shares. The RSU vesting is a routine equity compensation event, while the subsequent sale monetizes a portion of the newly vested shares but is structured under a trading plan, indicating pre-planned diversification rather than opportunistic insider selling.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0002028640-26-000007

Alert Tier

6